Femme et Homme
- | Pays :
- Canada
- Russian Federation
- France
- Les 4 autres...
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of the study is to evaluate the efficacy of atorvastatin 80 mg daily as compared to atorvastatin 10 mg daily in reducing C-reactive protein levels over a 26-week treatment period in subjects with documented coronary artery disease.
Critère d'inclusion
- Coronary Arteriosclerosis ,Hypercholesterolemia